HealthcareNYSE
Institutional-grade research for retail investors
SEC EDGAR: CIK 70318THC stock profile & AI dashboard →

13F Pro Quality Score

66.6/100

Rank #510 of 2,879 stocksTOP 25%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

37.6/100

Profitability

61.4/100

Balance Sheet

84.3/100

Earnings Quality

27.7/100

Free Cash Flow

75.3/100

Institutional Flow

75.5/100

Revenue Scale

93.1/100

Dilution Risk

75.7/100

THC Stock Analysis & AI Quality Score

AI stock analysis and institutional research for TENET HEALTHCARE CORP (THC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores THC at 66.6/100 on a 32-signal composite quality model, placing it at rank #510 of 2,879 stocks — the top 25% of the AI-ranked universe. THC scores in the top quartile across revenue scale (93.1), balance sheet strength (84.3), institutional flow (75.5). Areas of concern include earnings quality (27.7) and revenue growth (37.6), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), TENET HEALTHCARE CORP reports quarterly revenue of $5.4B, net income of $906.0M, free cash flow of $1.5B. Top institutional holders of THC by reported 13-F value include BlackRock,, FMR, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. THC trades on the NYSE exchange and files with the SEC under CIK 70318. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate THC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TENET HEALTHCARE CORP directly from SEC EDGAR.

Revenue

Q1 2026

$5.4B

Net Income

Q1 2026

$906.0M

Free Cash Flow

Q1 2026

$1.5B

ROIC

Q1 2026

7.2%

D/E Ratio

Q1 2026

2.74

Get alerted when THC's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for TENET HEALTHCARE CORP including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of THC

Put THC on your watchlist

Track score changes the day TENET HEALTHCARE CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is THC a good stock to buy?

13F Pro's AI-powered analysis of TENET HEALTHCARE CORP (THC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for THC are available on the THC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own THC?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling THC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of TENET HEALTHCARE CORP's investment landscape.